Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul 11:8:123.
doi: 10.3389/fpsyt.2017.00123. eCollection 2017.

Ultra-High-Field Magnetic Resonance Spectroscopy in Psychiatry

Affiliations
Review

Ultra-High-Field Magnetic Resonance Spectroscopy in Psychiatry

Beata R Godlewska et al. Front Psychiatry. .

Abstract

The advantages of ultra-high-field (UHF ≥ 7T) MR have been demonstrated in a variety of MR acquisition modalities. Magnetic resonance spectroscopy (MRS) can particularly benefit from substantial gains in signal-to-noise ratio (SNR) and spectral resolution at UHF, enabling the quantification of numerous metabolites, including glutamate, glutamine, glutathione, and γ-aminobutyric acid that are relevant to psychiatric disorders. The aim of this review is to give an overview about the advantages and advances of UHF MRS and its application to psychiatric disorders. In order to provide a practical guide for potential applications of MRS at UHF, a literature review is given, surveying advantages and disadvantages of MRS at UHF. Key concepts, emerging technologies, practical considerations, and applications of UHF MRS are provided. Second, the strength of UHF MRS is demonstrated using some examples of its application in psychiatric disorders.

Keywords: magnetic resonance spectroscopic imaging; magnetic resonance spectroscopy; neurochemicals; psychiatric disorders; ultra-high-field.

PubMed Disclaimer

Figures

Figure 1
Figure 1
In vivo stimulated echo acquisition mode spectrum (volume of interest, 8 ml, TE = 6 ms, TR = 5 s and number of transients, 160) and LCModel fit, modeling metabolite contributions to the neurochemical profile. Model spectra for glycerophosphocholine, phosphocholine, creatine, phosphocreatine, γ-aminobutyric acid, glucose, glutamine, Glutamate, glutathione, lactate, myo-inositol, N-acetylaspartate, N-acetylaspartylglutamate, scyllo-inositol, and taurine were imported into LCModel (17) and used for spectroscopic quantification [reprint McKay and Tkác (18)].
Figure 2
Figure 2
Representative in vivo 1H magnetic resonance spectroscopy spectra obtained in a healthy volunteer. All spectra obtained in one subject are shown (semi-LASER, TE = 28 ms at 3 T and TE = 26 ms at 7 T, TR = 5 s, 64 transients), with the four spectra obtained per brain region/field overlaid in each panel. The voxel locations are shown on the T1-weighted images [reprint Terpstra et al. (16)].
Figure 3
Figure 3
Simulated 1H magnetic resonance spectroscopy spectra of glutamate and glutamine at a range of field strengths [reprint Tkác et al. (41)].

References

    1. Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiatry (2016) 3(2):171–8.10.1016/S2215-0366(15)00505-2 - DOI - PubMed
    1. Birur B, Kraguljac NV, Shelton RC, Lahti AC. Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder—a systematic review of the magnetic resonance neuroimaging literature. NPJ Schizophr (2017) 3(1):15.10.1038/s41537-017-0013-9 - DOI - PMC - PubMed
    1. Treadway MT, Pizzagalli DA. Imaging the pathophysiology of major depressive disorder – from localist models to circuit-based analysis. Biol Mood Anxiety Disord (2014) 4(1):5.10.1186/2045-5380-4-5 - DOI - PMC - PubMed
    1. Reinecke A, Filippini N, Berna C, Western DG, Hanson B, Cooper MJ, et al. Effective emotion regulation strategies improve fMRI and ECG markers of psychopathology in panic disorder: implications for psychological treatment action. Transl Psychiatry (2015) 5:e673.10.1038/tp.2015.160 - DOI - PMC - PubMed
    1. Hampson DR, Blatt GJ. Autism spectrum disorders and neuropathology of the cerebellum. Front Neurosci (2015) 9:420.10.3389/fnins.2015.00420 - DOI - PMC - PubMed

LinkOut - more resources